CRT 2020

A computational scientist at CBSET, Boston, MA, USA. Features in 1 video on Wondr Medical. Abraham Tzafriri generally speaks on Stroke, Venous (PVD), Peripheral Vascular Disease (PVD), and Aortic Pathology.

Ailin Barseghian is an interventional cardiologist at Healing Hearts Counseling Center, Ohio, US.

Dr. Lansky is a Professor of Medicine in the section of Cardiology at the Yale School of Medicine, and is a practicing cardiologist at Yale-New Haven Hospital in New Haven, CT. She has dedicated her career to leading clinical and angiographic evaluations of more than 500 clinical trials in a broad range of ischemic cardiovascular therapeutic areas, including pharmacologic and interventional device trials, many of which are landmark trials in the field and/or leading to FDA approval in the United States. She has served as the principal investigator on numerous national and international imaging studies, devices, DES, and neuroprotection trials. Dr. Lansky has authored and coauthored over 500 academic peer-reviewed manuscripts in the fields of interventional cardiology, angiography, and women’s cardiovascular health. She chaired the American Heart Association Statement on Interventions in Women and most recently the Academic Research Consortium defining Neurologic Endpoints in clinical cardiovascular trials.

Alin Gragossian is an emergency medicine resident at UPMC Pinnacle Health System, Pennsylvania, US.

Works at CVPath Institute, Inc., Gaithersburg, MD, USA. Features in 2 videos on Wondr Medical. Aloke Finn generally speaks on Drug coated balloons (DCB), Primary Percutaneous Coronary Intervention (PPCI), Stents, Drug Eluting Stents (DES), and In-stent Restenosis (ISR).

Amir Kaki is a consultant/attending.

Anthony N DeMaria is a consultant cardiologist at UC San Diego, La Jolla, CA, USA.

Arie Pieter Kappetein works at Thorax Centre Erasmus MS, Rotterdam, The Netherlands.

Arnold Seto MD MPA is the Director of Interventional Cardiology Research at University of California, Irvine and Cath Lab Director at the Long Beach Veterans Affairs Medical Center. He was an active participant in the DEFINE-FLAIR and DEFINE-PCI trials, and a steering committee member for DEFINE-PCI. He has published multiple manuscripts in coronary artery disease, coronary physiology, and vascular access especially in the areas of accurate measurement of FFR and ultrasound guidance for radial and femoral access.

Works at MedStar Washington Hospital Center, Washington, District of Columbia, USA. Features in 14 videos on Wondr Medical. Augusto Pichard generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI), Valvular heart disease, Live Cases, Left Main Stem (LMS), and Rotational Atherectomy.

Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.

Barry Rutherford works at Saint Luke's Mid America Heart Institute, Shawnee Mission, KS, USA.

Biljana Parapid is an assistant professor of cardiology at School of Medicine , University of Belgrade, Belgrade, Serbia.

Works at Tenet- Florida, Delray Beach, FL. Features in 2 videos on Wondr Medical. Brijeshwar Maini generally speaks on Structural Cardiac Interventions, Cardiac Valves, Left Atrial Appendage (Closure), Left Main Stem (LMS), and Impella.

Dr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center (CSMC) in Los Angeles, California. Dr. Samuels completed his medical studies at Albert Einstein College of Medicine in New York before returning to Southern California to complete his residency and chief residency in Internal Medicine at Harbor-UCLA Medical Center. At CSMC, he trained in both general and interventional cardiology before joining the medical staff there. In addition to his clinical practice in coronary intervention, Dr. Samuels has actively participated in numerous interventional trials including IVUS guided therapy, coronary physiology and microvascular disease. He is also working closely with the Barbra Streisand Women’s Heart Center based at CSMC, working as an interventionalist in the active coronary reactivity research there. As co-chair of a 30-day readmissions task force, he has helped to shape policy for CSMC in its efforts to improve quality delivery of care. He has frequently been invited as faculty to many scientific meetings and is a sought after speaker for numerous peer educational platforms. Dr. Samuels is a fellow of the American College of Cardiology and is Board Certified in Internal Medicine, Cardiovascular Diseases, and Interventional Cardiology. He is married with three sons; his outside interests include contemporary art and long distance running.

Cara Hendry is an interventional cardiologist at Central Manchester University Hospitals, Manchester, UK.

Carlo Di Mario is Professor of Cardiology at the University of Florence and Director of the Structural 
Interventional Cardiology Division of the University Hospital Careggi, Florence, Italy. Previous posts included 15 years as Professor of Clinical Cardiology at Imperial College of Sciences, Medicine & Technology, London and Consultant Cardiologist at the Royal Brompton Hospital. Despite his teaching, research and administrative commitments, he maintains an active clinical involvement performing more than 100 PCI per year with special interest in the treatment of calcified lesions, chronic total occlusions, bifurcations, and diffuse disease. He is a regular TAVI operator and certified implanter for the Medtronic Evolut R and Edwards Sapien 3 transcatheter aortic valves. He participated in more than 160 MitraClip implantations in London and Florence and has recently started direct annuloplasty with the CardioBand. Professor Di Mario pioneered the use of intracoronary Doppler, pressure measurement, intravascular ultrasound, optical coherence tomography, and near infrared spectroscopy. He was PI of the OPTICUS trial, failing to demonstrate superiority of IVUS guided stenting, and of the Lipid Rich Plaque study, due to report at TCT 2018. He was Principal Investigator of the DESTINI trial, using Doppler CRF to identify lesions in need of stenting, and of the CARESS in AMI trial, a large multicentre trial showing that patients who receive fibrinolytic therapy for ST-elevation myocardial infarction benefit from early angioplasty. This trial and a subsequent meta-analysis have led to a change in the European Society of Cardiology and AHA/ACC Guidelines for treatment of STEMI patients. He cooperated with Dr Davies to the validation of iFR to assess lesion severity and discriminate the contribution of individual lesions, and with Dr Lyon in the intracoronary delivery of SERCA-2 genes via adenoviral vectors in the CUPID2 trial.

Carlos Mena-Hurtado is an associate professor of cardiology at Yale School of Medicine, New Haven, CT, USA.

Chiu Wong works at Weill Medical College of Cornell Univeristy, New York, NY, USA.

Works at Ochsner Medical Institutions, New Orleans, LA, USA. Features in 1 video on Wondr Medical. Christopher White generally speaks on Stroke, Peripheral Vascular Disease (PVD), and Live Cases.

Chuck Simonton is an industry at Abbott Vascular.

Crispin Davies is a cardiologist at Oregon Health and Science University, Portland, Oregon, USA.

Danielle Belardo is a cardiology fellow at Lankenau Medical Center, Pennsylvania, US.

Works at UW Medical Centre, Redmond, Washington, USA. Features in 3 videos on Wondr Medical. Danny Dvir generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI), Cardiac Valves, Cardiovascular Surgery – Valves, MitraClip, and TAVR Access Sites.

Danny Steinberg is a professor of medicine at Medical University of South Carolina, Charleston, SC, USA.

David J. Cohen, MD, MSc is currently Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation (New York, NY) and Director of Academic Affairs at St. Francis Hospital (Roslyn, NY). Previously, he was Professor of Medicine at the University of Missouri–Kansas City and Director of Cardiovascular Research and Medical Director of Health Economics and Technology Assessment at Saint Luke’s Mid America Heart Institute. Heart Institute where he continues to direct the Health Economics and Technology Assessment Group. Dr. Cohen earned his M.D. at Harvard Medical School and his Master's degree in Health Policy at the Harvard School of Public Health. He did his clinical training at Brigham and Women's Hospital and was a clinical and research fellow in cardiology at Beth Israel Hospital for five years. Dr. Cohen is a practicing interventional cardiologist with a focus on structural and valvular heart disease. His research focuses on the application of formal cost-effectiveness methodology to novel interventions for cardiovascular disease (CVD), the extension of traditional cardiovascular outcomes research to include patient-centered outcomes, and the development and evaluation of instruments for assessing CVD patients’ health status and preferences. He is also active in research to determine the short- and long-term outcomes of new devices for percutaneous coronary revascularization and identifying the optimal target populations and techniques for these devices. Dr. Cohen has published more than 500 original articles in leading journals, including the New England Journal of Medicine, Lancet, JAMA, Circulation, and the Journal of the American College. Dr. Cohen serves on the editorial board for the American Heart Journal, JACC Interventions, and Circulation and reviews for the American Journal of Cardiology, Journal of the American College of Cardiology, New England Journal of Medicine, JAMA, and Medical Decision Making.

Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.

A professor of medicine at Stanford University Medical Center, Stanford, CA, USA. Features in 1 video on Wondr Medical. David Maron generally speaks on Dobutamine Stress Echo (DSE), Stable Coronary Artery Disease (CAD), and Positron Emission Tomography (PET).

David Zhao works at Wake Forest Baptist Medical Center, Winston Salem, NC, USA.

Works at Ferrarotto Hospital, University of Catania, Catania, Sicilia, Italy. Features in 8 videos on Wondr Medical. Davide Capodanno generally speaks on Cardiovascular Pharmacotherapy, Cardiac Valves, Covid-19, Covid19 Managing Covid, and Dobutamine Stress Echo (DSE).

Works at The Christ Hospital Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH, USA. Features in 9 videos on Wondr Medical. Dean Kereiakes generally speaks on Peripheral Vascular Disease (PVD), Coronary Interventions, Impella, Shockwave Lithotripsy (Coronary), and Transcatheter Aortic Valve Implantation (TAVR / TAVI).

Works at University of Florida College of Medicine - Jacksonville, Jacksonville, FL, USA. Features in 2 videos on Wondr Medical. Dominick Angiolillo generally speaks on Coronary Interventions, Anti-Platelet Drugs , Stable Coronary Artery Disease (CAD), Acute Coronary Syndromes (ACS), and Primary Percutaneous Coronary Intervention (PPCI).

Works at Beth Israel Deaconess Medical Center, Boston, MA, USA. Features in 1 video on Wondr Medical. Donald Cutlip generally speaks on Anti-Platelet Drugs and Drug Eluting Stents (DES).

Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Cardiology and Director of Interventional Cardiology at Stanford University School of Mediciner. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation. Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and was a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He is now the principal investigator of the international FAME 3 trial comparing bypass surgery to fractional flow reserve guided percutaneous coronary intervention. He serves on the editorial board of the Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He was the principal investigator on an R01 and is the PI on an R61/R33 NIH award evaluating cardiac allograft vasculopathy early after transplantation. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement. He was a coauthor on the PARTNER 2A Trial published in the New England Journal of Medicine.

Edward Koifman works at MedStar Washington Hospital Center, Washington, DC, USA.

Elias Haddad works at Tennessee Valley Healthcare System-Nashville, Nashville, TN, USA.

Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI is Director of the Center for Complex Coronary Interventions at the Minneapolis Heart Institute and Chairman of the Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation. After graduating from Lycee Leonin de Patissia, Dr. Brilakis received his medical degree from the National Kapodistrian University of Athens, Greece. He trained in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology at the Mayo Clinic. He also completed a Masters in Clinical Research at the Mayo Clinic and a PhD in Clinical Research at the National Kapodistrian University of Athens, Greece. He served as director of the cardiac catheterization laboratories at VA North Texas Health Care System from 2004-2016. He was on the faculty of the University of Texas Southwestern Medical School from 2004-2018. Dr. Brilakis leads a large clinical trial group investigating treatment of chronic total occlusions, prevention and treatment of saphenous vein graft disease, prevention and management of complications, intracoronary imaging, antiplatelet treatment optimization post coronary stenting, radiation safety in the catheterization laboratory, and implementation of novel technologies in healthcare. Dr. Brilakis has authored or co-authored over 600 manuscripts and has written the Manual of CTO Interventions, now in its second edition. He directs the Complex Coronary Interventions Webcast series and is on the Board of the Cardiovascular Innovations Foundation. He is an associate editor for Circulation and an editorial board member and reviewer for several journals and grant agencies. He is lecturing and proctoring at several institutions in the United States and abroad.

Emmanuel Messas is an interventional cardiologist at European Hospital Georges Pompidou, Paris, France.

Works at Vascular Institute of the Midwest, PC, USA. Features in 4 videos on Wondr Medical. Eric Dippel generally speaks on Peripheral Vascular Disease (PVD), Atherectomy, Live Cases, Endovascular, and Chronic Total Occlusion (CTO).

Prof Erick Schampaert is a Professor of Medicine, University of Montreal. He has been Interventional cardiologist, Hôpital du Sacré-Cœur de Montreal, since 1997, serving as Head of Division of Cardiology since 2006; Chair, CIUSSS NIM HSCM Cardiovascular Health Program since 2014 and Director of Clinical CV Research unit since 2001. Prof Schampaert’s research is focused mainly on Left Main PCI, Coronary physiology (FFR, iFR, CFR), Coronary imaging (IVUS and OCT), and ACS (STEMI) and platelet functions. Prof Schampaert is a Local PI for more than 75 clinical trials and is an author or co-author of more than 75 manuscripts in journals such as NEJM, Lancet, Circulation, JACC, EHJ.

Dr. Ethan Weiss is a cardiologist specializing in general cardiology. His special interests include preventive cardiology, genetics of coronary disease, risk assessment, and heart disease in the young.

Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on SCAI's IHD Council and is a co-director of Optimizing PCI (OPCI). His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 100 publications in peer-reviewed journals.

Dr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and Computational Sciences, and received in MD and PhD in Biophysics from the University of Pennsylvania of Medicine in 1996. He completed a residency in internal medicine at the Brigham and Women's Hospital, followed by a fellowship in cardiovascular medicine and interventional cardiology at Massachusetts General Hospital. In 2003, he joined the Cardiology Division as faculty. Dr. Jaffer is currently an Associate Professor of Medicine at Harvard Medical School and an Attending Interventional Cardiologist at Massachusetts General Hospital. He is Director of Coronary Intervention and Director of the Chronic Total Occlusion (CTO) PCI Program at at Massachusetts General Hospital. The MGH is a leading center for treating the most complex coronary blockages, such as CTO. Many patients, previously without options, have successfully underwent CTO PCI, and have experienced marked reductions in angina (chest pain) and shortness of breath. Dr. Jaffer is also a Principal Investigator in the MGH Cardiovascular Research Center where his NIH-funded laboratory develops novel molecular imaging approaches to image high-risk plaques and blood clots, to better prevent heart attacks, strokes, and venous blood clots.

Fayaz Shawl works at Washington Adventist Hospital, Takoma Park, MD.

Professor Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital, and Affiliate/Visiting Professor Harvard-MIT Biomedical Engineering, Institute of Medical Engineering and Science, Cambridge, US. Professor Mahfoud completed training in Cardiology and Interventional Cardiology at the Department for Internal Medicine III, Saarland University Hospital, Germany in 2014. Since 2017, he has served as Vice Chairman of the ‘Working Group on Interventional Hypertension Treatment’ for the European Society of Hypertension, and as a Committee Member of the 2018 Hypertension Guidelines.

Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.

Dr Giora Weisz is the Section-Head and director of the interventional cardiology program at Montefiore Medical Center in New York. He also serves as faculty of the Cardiovascular Research Foundation in New York. Dr Weisz graduated from the Hebrew University-Hadassah Medical School in Jerusalem, Israel. He completed his cardiology fellowship training at the Carmel Medical Center-Technion School of Medicine in Haifa, Israel, and underwent advanced training in interventional cardiology at Lenox Hill Hospital and the Cardiovascular Research Foundation in New York City. Dr Weisz is an internationally recognized researcher focused on innovative technologies in cardiovascular medicine. He has pioneered the use of novel robotic-enhanced coronary interventions, navigation and positioning technologies. Dr Weisz has been the Principal Investigator for pivotal clinical studies leading to FDA approval of cutting-edge technologies for interventional cardiology device positioning and navigation and robotics, as well leading multicenter studies in interventional imaging and the combination of PCI with pharmacological anti-ischemic treatment. Dr Weisz has published extensively in the most prestigious peer-review medical journals. He is an associate-director of TCT, which is the premier interventional cardiology conference, and is a regular faculty member for the most important international cardiovascular meetings.

Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.

Works at Hadassah Medical Center, Jerusalem, Israel. Features in 1 video on Wondr Medical. Haim Danenberg generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI) and Aortic Stenosis (AS).

Hans Bonnier works at University Hospital Brussels, Nuenen, Noord-Brabant, Netherlands.

Hector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart & Vascular Institute and director of the Coronary Invasive Imaging Core Lab. Prior to joining the MHVI medical staff, Dr. Garcia-Garcia served as Director of the Core Lab of Invasive Imaging at Cardialysis—a leading cardiology clinical research organization—and as researcher at the Erasmus Medical Center in Rotterdam, The Netherlands and Inselspital in Bern, Switzerland. He received both a Master’s and Doctorate degree from the Erasmus University of Rotterdam. An accomplished researcher, Dr. Garcia-Garcia has widely published in many international medical journals (more than 530 publications - H-index of 61), authored book chapters in most renowned cardiovascular textbooks and has presented at cardiology conferences world-wide. He is an expert in innovative cardiovascular technology. He has mentored seven PhD students and published their thesis.

A consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on Wondr Medical. Horst Sievert generally speaks on Atrial Fibrillation, Left Atrial Appendage (Closure), Live Cases, Transcatheter Aortic Valve Implantation (TAVR / TAVI), and Left Main Stem (LMS).

Works at Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Features in 20 videos on Wondr Medical. Howard Herrmann generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI), Mitral, Mitral regurgitation, MitraClip, and Structural Cardiac Interventions.

Howard Julien is an assistant professor of medicine at Hospital of the University of Pennsylvania, Pennsylvania, USA.

Professor Ian Meredith is the Executive Vice President and Global Chief Medical Officer at Boston Scientific. Previously professor and director of Monash Heart, and executive director of the Monash Cardiovascular Research Centre at Monash University in Melbourne, Australia, Professor Meredith has over 25 years of experience as a clinical and interventional cardiologist. Professor Meredith has been a member of the Board of the National Heart Foundation (Australia) and a member of the Cardiac Society of Australia and New Zealand National Board. In 2019, Professor Meredith received a Doctor Laws honoris causa from Monash University for distinguished and exceptional service to the field of medicine and healthcare.

Ileana Pina works at Montefiore Medical Center, Bronx, NY, USA.

Isaac George works at Division of Cardiothoracic Surgery, College of Physicians and Surgeons.

Jaffar is Director of Cardiovascular Innovation and Director of Interventional Electrosurgery at St Francis Hospital and Heart Center, Roslyn, NY. He performs research at the Laboratory of Cardiac Intervention, NHLBI, NIH. He led the invention of transcatheter electrosurgical techniques to cut heart tissue, and together with a team of dedicated physicians and creative thinkers, invented several novel transcatheter procedures and devices that have been translated into clinical practice. He received his undergraduate degree at Cambridge as a Scholar, medical degree at Oxford with merits, and an award-winning PhD in cardiovascular sciences at King’s College London. He completed training in Oxford, London, and Washington DC. He has written over 130 peer-reviewed manuscripts and has given over 50 invited lectures, including 4 late breaking clinical trial presentations. He is a regular live case operator.

Dr. James Stephen Jenkins, MD, FACC, FSCAI, FSVM Section Head, Interventional Cardiology Director, Interventional Cardiology Research John Ochsner Heart and Vascular Institute Associate Professor of Medicine, Ochsner Clinical School, Univ. Queensland New Orleans, LA Education: Medical School: University of Arkansas Medical Center in Little Rock Fellowship Training: Internal Medicine and Cardiology, University of Missouri Health Science Center Columbia. Interventional Cardiology Fellowship, Ochsner Medical Center. Clinical Interests: Specializes in Interventional Cardiology, including Coronary, Peripheral & Structural intervention, carotid stenting, percutaneous mitral, aortic, septal, LAA and venous intervention. He is the Director of Interventional Cardiology Research, an active clinical researcher and has written numerous articles and chapters for scientific medical publications.

James Zidar works at University of North Carolina/Rex Healthcare, Raleigh, NC, USA.

Janusz Lipiecki is an interventional cardiologist at University Hospital, University of Clermont-Ferrand, Auvergne, France.

Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico San Carlos / Complutense University (Madrid, Spain). He trained in the United Kingdom as Specialist in Cardiology and obtained his PhD in The Netherlands. Author of >600 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 74) and over 30 years of experience as PCI operator, he regularly lectures and performs live cases at major scientific and educational meetings. He is a recipient of the European Society of Cardiology (ESC) Silver Medal and the Andreas Grüntzig Award for his contributions to the fiedl fo Interventional Cardiology. Main areas of expertise include complex PCI, intracoronary diagnostics and functional coronary angiography. His track record in coronary physiology comprises being investigator on pioneer FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR, and developer of new tools for the assessment of coronary microcirculation. Editorial roles include Deputy Editor EHJ, Advisory Editor Eurointervention, editor of the textbooks “Coronary Stenosis: Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation". Recent board positions include EAPCI board / Education Committee Chair, ESC WG Coronary Pathophysiology and Microcirculation, EuroCTO Board. Recent trials as Principal Investigator include ADVISE II, DEFINE FLAIR, SYNTAX II, PIONEER IV, Cerebral-Coronary-Connection (C3), DCR4Contrast, INOCA LongCovid and AID ANGIO. Additional interests are philosophy and music.

Jay Giri works at University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Jeffrey Chambers is a cardiology at Metropolitian Heart and Vascular Institute, Minneapolis, MN, USA.

Works at UC Davis Medical Center, West Sacramento, CA, USA. Features in 1 video on Wondr Medical. Jeffrey Southard generally speaks on General, Structural Cardiac Interventions, Mitral, and Left Atrial Appendage (Closure).

Jeong-Eun Yi is a professor of cardiology at The Catholic University of Korea, Seoul, South Korea.

ESC Immediate Past-President (2018 – 2020), Jeroen Bax is Director of non-invasive imaging and Director of the echo-lab at the Leiden University Medical Center. His main interests include clinical cardiology, heart failure, cardiac resynchronization therapy and the application of all different imaging modalities to these clinical fields. Professor Bax has authored numerous papers and holds several positions in national and international scientific organizations, as well as serving on the editorial boards of many different journals.

Dr. Douglas is Professor of Medicine and Director of the Interventional Cardiology Fellowship Program at Emory University. He is a graduate of the University of the South and received his M.D. degree from Washington University School of Medicine in St. Louis. He completed residency in Internal Medicine at the University of North Carolina and at Emory University. Dr. Douglas was a Lieutenant Commander in the United States Navy Medical Corps and served at the Camp Lejeune Marine Corps Base and in An Hoa, South Vietnam. In 1980 Dr. Douglas was a member of the team that performed the first coronaryangioplasty at Emory University Hospital and in 1987 the first coronary stent in the United States . Dr Douglas was a partner of the late Andreas Gruentzig, the inventor of coronary angioplasty and participated in the development of current coronary angioplasty and stent techniques. He has mentored over one hundred and fifty interventional cardiology fellows. He is a Fellow and prior member of the Board of Governors of the American College of Cardiology and Society for Cardiac Angiography and Intervention and is currently listed in Castle Connolly Guide of America’s Top Doctors, Atlanta’s Top Doctors and The Best Doctors in America. He received the American College of Cardiology Lifetime Achievement Award, the Distinguished Alumnus Award from the University of the South and the SCAI Mason F. Sones, Jr., MD, Distinguished Service Award.

McLeod Professor of Heart Valve Innovation, University of British Columbia Dr. Webb is the director of interventional cardiology at St. Paul’s Hospital, McLeod Professor at UBC, Medical Director of the Transcatheter Valve Program for the Province of BC. As director of the Centre for Heart Valve Innovation, he leads the group that developed the most widely used transcatheter aortic valve implantation procedures as well as many other first-in-human devices and procedures. He has performed or supervised over 3,000 aortic, mitral, pulmonary, and tricuspid valve procedures in over 30 countries throughout North America, Europe, and Australasia and has authored over 500 publications.

John P Reilly is an intensive care physician at Hospital of the University of Pennsylvania, Pennsylvania, USA.

Jolanta Siller-Matula is an assistant professor of medicine at Medical University of Warsaw, Warsaw, Poland.

Jonathon Leipsic is a professor of radiology at St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.

Jorge Saucedo is a professor of cardiology at University of Wisconsin School of Medicine, Madison, WI, USA.

An associate professor of medicine at Stanford University Medical Center, Stanford, CA, USA. Features in 3 videos on Wondr Medical. Jung-Sun Kim generally speaks on Mitral regurgitation, MitraClip, Live Cases, and Imaging.

Dr Justin Davies is a honorary 
interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to
work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents,
he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).

Dr. Karim Al-Azizi is an Interventional Cardiologist and Structural Heart Disease specialist at Baylor Scott & White Health - The Heart Hospital in Plano, TX. He is the Medical Director of the Cardiac Catheterization Laboratories and the Associate Program Director of the Cardiovascular disease fellowship and a clinical assistant professor at the Texas A and M College of Medicine. His clinical and research interests include complex coronary interventions, ultra-low contrast, physiology and imaging-guided PCI, and transcatheter interventions for valvular heart disease. He speaks at national and international conferences on these subjects and serves as a principal investigator on multiple clinical trials in the field of structural and coronary interventions.

Katherine Thayer is a senior lecturer at University of Southern Maine College of Nursing, Portland, Maine, US.

Keith Dawkins works at Boston Scientific.

Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program at Brigham and Women’s Hospital (BWH). He is an assistant professor of medicine at Harvard Medical School (HMS) who also directs the BWH Translational Discovery Laboratory which is a centralized research facility that uses state-of-the-art technology to perform preclinical testing of promising therapies and medical devices. Dr. Croce received his medical and Ph.D. degrees from Tufts University School of Medicine. He completed an internal medicine residency, a cardiology fellowship and an interventional cardiology fellowship at BWH. Dr. Croce is board certified in internal medicine, cardiovascular disease and interventional cardiology. His clinical interests include advanced treatments for obstructive coronary artery disease (CAD), and optimization of antithrombotic and antiplatelet pharmacotherapy. The author of over 50 peer-reviewed publications, Dr. Croce’s research focuses on understanding the molecular pathobiology of atherothrombotic (CAD) and on identifying new targets for CAD treatment. His research has received support from the National Institutes of Health.

Dr. Niazi's research has advanced the field of interventional cardiology by focusing on peripheral vascular disease and coronary artery disease. At Emory, Dr. Niazi initiated the peripheral research program that continues to perform multiple studies, including studies for novel devices for FDA approval to help patients' circulation. Dr. Niazi is one of the few cardiologists that treats venous disease along with arterial disease.

Works at Geisinger Medical Center, Danville, PA, USA. Features in 1 video on Wondr Medical. Kimberly Skelding generally speaks on Dobutamine Stress Echo (DSE), Stable Coronary Artery Disease (CAD), and Positron Emission Tomography (PET).

A professor of cardiology at Keele University, Keele, United Kingdom. Features in 3 videos on Wondr Medical. Mamas Mamas generally speaks on Cardiovascular Pharmacotherapy, Covid-19, Covid19 Managing Covid, Drug coated balloons (DCB), and Primary Percutaneous Coronary Intervention (PPCI).

A chief innovation officer at University of Pennsylvania, Philadelphia, PA, USA. Features in 1 video on Wondr Medical. Mark Turco generally speaks on Innovation, Peripheral Vascular Disease (PVD), and Vascular Access (Endovascular).

Marta Bande is a cardiologist at Istituto Clinico Sant'Ambrogio, Milan, Italy.

Marvin Eng works at Henry Ford Hospital, Detroit, MI, USA.

A consultant cardiologist at Sayama Hospital, Saitama, Japan. Features in 4 videos on Wondr Medical. Masahisa Yamane generally speaks on Chronic Total Occlusion (CTO), Live Cases, Bifurcation, Total Occlusion and Bifurcation Interventions, and Coronary Artery Bypass Grafting (CABG).

Mauricio Cohen works at University of Miami Miller School of Medicine, Miami, FL, USA.

Megan Coylewright works at Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

Michael Dwyer works at University at Buffalo, Buffalo, NY, USA.

An interventional cardiologist at Municipal clinics Neuss, Lukas hospital GmbH, Neuss, Germany. Features in 4 videos on Wondr Medical. Michael Haude generally speaks on Intravascular Ultrasound (IVUS), Coronary Interventions, Interventional Cardiology Review, Coronary Artery Bypass Grafting (CABG), and Interventional Cardiology - Other.

Works at Deutsches Herzzentrum Muenchen, Munich, Bayern, Germany. Features in 13 videos on Wondr Medical. Michael Joner generally speaks on Stents, Drug Eluting Stents (DES), Peripheral Vascular Disease (PVD), Intravascular Ultrasound (IVUS), and Coronary Optical Coherence Tomography (OCT).

Dr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the Associate Director of Interventional Cardiology Research at the UCLA Medical Center. Dr. Lee has published over 110 (over 70 of which were as first author) peer reviewed articles and chapters. He has also published on topics including antithrombotic therapy in patients with acute coronary syndrome and in percutaneous coronary intervention, protocols to establish heparin dosing regimens, and percutaneous coronary intervention for the treatment of left main disease, saphenous vein grafts, and cardiac allograft vasculopathy who have undergone orthotopic heart transplantation. He is one of the world’s authorities in coronary and peripheral orbital atherectomy.

Works at Houston Methodist Hospital, Houston, Texas, USA. Features in 24 videos on Wondr Medical. Michael Reardon generally speaks on Aortic Stenosis (AS), Transcatheter Aortic Valve Implantation (TAVR / TAVI), Cardiovascular Surgery, Femoral, and Mitral.

Dr. Rinaldi is board certified in cardiology and specializes in interventional cardiology and vascular medicine. He is recognized as a national and international thought leader and an expert in the fields of coronary, peripheral and structural heart interventions, including transcatheter mitral valve repair and replacement, transcatheter aortic valve replacement, transcatheter tricuspid valve repair and left atrial appendage occlusion. He is the medical director of the Structural Heart Program at Atrium Health Sanger Heart & Vascular Institute, a professor of medicine at the University of North Carolina and a faculty member of The International Andreas Gruentzig Society. He formerly served for a decade as the medical director of research of the Structural Heart Program. Dr. Rinaldi has been recognized as a Top Doctor by the Charlotte Business Journal and Physician of the Quarter by Atrium Health Carolinas Medical Center. He is a member of the Alpha Omega Alpha Honor Medical Society. As the medical director of research at Sanger Heart & Vascular Institute for 10 years, he has served as a principal or sub investigator for numerous clinical trials involving thousands of patients. His current research interests include transcatheter mitral, aortic, tricuspid valve therapies, including novel devices and techniques through clinical trials and research.

Michael Singh works at UPMC, Pittsburgh, PA, USA.

Michael Slack works at University of Maryland Medical Center, Baltimore, MD, USA.

Michael Stoner works at University of Rochester, Rochester, New York, NY, USA.

Dr Mirvat Alasnag was the first female interventional cardiologist in the Gulf region and represented women on multiple committees. She is currently the Chair of the International Working Group of the ACC Women in Cardiology Committee, a member of the SCAI Board of Trustees and ACC Interventional Leadership Council. She is also the chair of the Interventional Cardiology working group of the Tele-Cardiology Section of the International Society for Telemedicine & eHealth. She is a contributing editor & associate editor for several renowned international journals and societies including Circulation: Cardiovascular Interventions, ACCEL, Open Heart, Cardiovascular Revascularization Medicine, and PCROnline. She has served as a peer reviewer for several ACC Guideline Statements.

Works at UCSD Sulpizio Cardiovascular Center and VA San Diego, La Jolla, CA, USA. Features in 1 video on Wondr Medical. Mitul Patel generally speaks on Chronic Total Occlusion (CTO), Drug Coated Balloon (DCB), and Endovascular.

Molly Szerlip is an interventional cardiologist.

Dr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine, University California, Irvine. He continues to perform and teach cardiac catheterization and PCI. Dr. Kern is ABIM Certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology and is a past president and now a Master Fellow of the SCAI. His research interests in coronary blood flow, intravascular physiology, intravascular ultrasound, vulnerable plaque and evaluation of cardiovascular hemodynamics. He has authored several textbooks, notably The Cardiac Catheterization Handbook, 6th ed. and its companion The Interventional Cardiac Cath Handbook, 4th ed.

Works at Tufts Medical Center, Boston, MA, USA. Features in 5 videos on Wondr Medical. Navin Kapur generally speaks on Primary Percutaneous Coronary Intervention (PPCI), ST-Elevation Myocardial Infarction (STEMI), Cardiology, Cardiovascular Surgery - Circulatory Support, and Coronary Intervention: Devices.

Nicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of Interventional Cardiology at the Thoraxcenter, Erasmus University Medical Center, Rotterdam. He obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in at Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, United States and Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands, he joined the senior staff of the department of interventional cardiology in the Thoraxcenter in February 2010. Professor Van Mieghem’s academic interest is in complex (calcified) coronary lesions, mechanical circulatory support and structural heart interventions. He obtained a PhD based upon his research in transcatheter valve therapies. Professor Van Mieghem is involved in the percutaneous coronary interventions and structural heart program. Professor Van Mieghem has published and co-authored over 400 scientific papers in peer-reviewed journals. He is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and the American College of Cardiology.

Paul Sorajja works at Abbott Northwestern Hospital, Minneapolis, MN, USA.

Peter Libby is a consultant cardiologist at Brigham and Women's Hospital, Boston, MA, USA.

Philippe Blanke is an assistant professor of radiology at University of British Columbia.

Works at Morristown Medical Center, Morristown, NJ, USA. Features in 5 videos on Wondr Medical. Philippe Genereux generally speaks on Shockwave Lithotripsy (Coronary), Coronary Optical Coherence Tomography (OCT), Stable Coronary Artery Disease (CAD), and Calcified Lesions.

A cardiologist at MedStar Washington Hospital Center, Washington, DC, USA. Features in 3 videos on Wondr Medical. Preetham Kumar generally speaks on Left Ventricular Assist Device (LVAD).

Rafael Beyar works at Rambam Helath Care Camous, Haifa, Israel.

Dr. Rajan Patel, MD FACC FAHA FSCAI is the program director of the interventional cardiology fellowship program at Ochsner Medical Center in New Orleans, LA. Dr. Patel's clinical practice focuses on the percutanous treatment of complex coronary artery diease including CTO's as well as peripheral artery disease. He also collaborates with the Ochsner Medical Center advanced heart failure and cardiothoracic surgery teams in providing cardiogenic shock patients with percutaneous mechanical circulatory support.

Works at Miami Cardiac & Vascular Institute, Miami, FL, USA. Features in 1 video on Wondr Medical. Ramon Quesada generally speaks on Chronic Total Occlusion (CTO), Alcohol Septal Ablation, Radial, Thrombus Aspiration, and Live Cases.

Works at CVPath Institute, Inc., Gaithersburg, MD, USA. Features in 6 videos on Wondr Medical. Renu Virmani generally speaks on Atherectomy, Coronary Optical Coherence Tomography (OCT), Drug Eluting Stents (DES), Live Cases, and Peripheral Vascular Disease (PVD).

In 2005, Richard became a consultant cardiologist at Cardiff and Vale NHS Trust seeing and treating patients both at the University Hospital of Wales and Llandough Hospital. He is specialised in coronary angiography and coronary angioplasty performing these procedures from the wrist allowing same day discharge for the majority of patients.

Richard Rapoza is an industry at Abbott Vascular.

Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.

Prof. Byrne graduated from University College Dublin, Ireland and completed his PhD in Medical Life Science and Technology at the Technical University Munich, Germany. Research awards received include the ESC Atherothrombosis Research Fellowship (2008), the TCT Thomas J. Linnemeier Young Investigator Award (2009) and the Andreas Grüntzig Research Prize of the German Cardiac Society (2016). Leadership roles include Deputy Editor at EuroIntervention and board member of EAPCI and Chair of its Patient Initiatives Committee.

A consultant cardiologist at Mount Sinai Hospital, New York, USA. Features in 13 videos on Wondr Medical. Roxana Mehran generally speaks on Anti-Platelet Drugs , Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), Cardiovascular Pharmacotherapy, and Cardiac Valves.

Saher Sabri is an interventional radiologist at MedStar Washington Hospital Center, Washington, DC, USA.

Works at The Commonwealth Medical College, Scranton, Clarks Summit, PA, USA. Features in 1 video on Wondr Medical. Samir Pancholy generally speaks on Radial and Acute Coronary Syndromes (ACS).

Sandeep Nathan works at University of Chicago Medicine, Chicago, Illinois, USA.

Works at VA Boston Healthcare System, West Roxbury, MA, USA. Features in 1 video on Wondr Medical. Scott Kinlay generally speaks on Aorta and Endovascular.

Scott Lim works at University of Virginia, Charlottesville, VA, USA.

Scott Russell is a professor of medicine at University of Kansas School of Medicine, Kansas, US.

Scott Shurmur is a chief of cardiology at Texas Tech Univeristy Health Sciences Center, Texas, US.

A medical doctor at Emory Healthcare, United States of America. Features in 5 videos on Wondr Medical. spencer King generally speaks on Cardiology, Structural Cardiac Interventions, and Interventional Cardiology - Other.

Dr. Steven Bailey is The Chairman of Medicine at LSU Shreveport and the Malcolm Feist Chair of Interventional Cardiology. He also is a Tenured and Emeritus Professor of Medicine and Radiology and previous Chief of the Janey and Dolph Briscoe Jr. Division of Cardiology at the University of Texas Health Science Center in San Antonio, Texas. Dr. Bailey received his medical degree from University of Oregon Health Science Center at Portland and did his medicine residency and cardiology fellowship at Fitzsimmons Army Medical Center in Aurora, Colorado. He is board certified by the American Board of Internal Medicine with subspecialty board certification in both Cardiovascular Disease and Interventional Cardiology. Dr. Bailey's clinical focus is in Adult Congenital/Structural and Valvular heart disease in addition to Coronary Atherosclerotic Disease. His research laboratory is involved in investigating the effects of NOX subtypes in promoting cardiovascular disease. He has translational research in the field of nanotechnologies and nanosensors and holds several patents in these fields. He was the Program Director for Interventional Cardiology at UTHSCSA from 1999 to 2019. Dr. Bailey chaired the UTHSCSA Promotion and Tenure committee. Dr. Bailey is a Past President of the Society for Cardiovascular Angiography and Interventions (SCAI) and is currently the Editor in Chief of Catheterization and Cardiovascular Interventions, which is the official publication of SCAI. He is a Master Fellow of SCAI, Fellow of the American College of Cardiology and a Fellow the American College of Physicians. He is a member of the Association of University Cardiologists, Association of Cardiology Professors as well as the International Andreas Greuntizig Society.

Steven Goldstein works at MedStar Washington Hospital Center, Washington, District of Columbia, USA and features in 1 video on Wondr Medical.

Steven Nissen works at Cleveland Clinic, Cleveland, OH, USA.

Works at OhioHealth/Riverside Methodist Hospital, Columbus, OH, USA. Features in 1 video on Wondr Medical. Steven Yakubov generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI) and Aortic Stenosis (AS).

Dr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of Cardiology at the Durham VA Medical Center. At the national level, Dr. Rao serves as the Editor-in-Chief for Circulation Cardiovascular Interventions, the interventional journal of the American Heart Association’s flagship Circulation family of journals. He is the President-Elect for The Society for Cardiovascular Angiography and Interventions, and serves on the program committees of the ACC Scientific Sessions, the Transcatheter Cardiovascular Therapeutics conference, and the SCAI Scientific Sessions. He was the chairman of the 2017 ACC-i2 Summit and was the chair of the SCAI 2019 Annual Scientific Session. In addition, he was the Editor-in-Chief of the ACC CathSAP 5 program and is currently the co-chair of the ACC Collaborative Management Pathway for Interventional Cardiology. His main research interests are pharmacological and interventional therapies for acute coronary syndromes, as well as bleeding and blood transfusion complications among patients with ischemic heart disease. Dr. Rao has published over 300 peer-reviewed papers, and is the co-Editor-in-Chief of the seminal textbook on transradial procedures titled “Best Practices for Transradial Approach in Diagnostic Angiography and Intervention.”

A medical doctor at Wakayama Medical University, Wakayama, Japan. Features in 16 videos on Wondr Medical. Takashi Akasaka generally speaks on Instantaneous wave-Free Ratio (iFR), Fractional Flow Reserve (FFR), Coronary Flow Reserve (CFR), Coronary Physiology, and Coronary Optical Coherence Tomography (OCT).

Works at Universitäts-Herzzentrum Freiburg, Bad Krozingen, Baden-Wurttemberg, Germany. Features in 19 videos on Wondr Medical. Thomas Zeller generally speaks on Drug Eluting Stents (DES), Drug Coated Balloon (DCB), Chronic Limb Ischaemia (CLI, coronary access), Critical Limb Ischaemia (peripheral), and Peripheral Vascular Disease (PVD).

Tim Fischell works at Borgess Heart Institute, Kalamazoo, MI, USA.

Works at Cedars-Sinai Medical Center, Los Angeles, CA, USA. Features in 1 video on Wondr Medical. Timothy Henry generally speaks on Primary Percutaneous Coronary Intervention (PPCI) and ST-Elevation Myocardial Infarction (STEMI).

Dr. Rogers is an interventional cardiologist and scientific lead for the MedStar Heart & Vascular Institute Structural Heart Disease program. He has a special interest in all aspects of minimally invasive treatment of structural heart disease, including Transcatheter Aortic Valve Replacement (TAVR), Transcaval access, Transcatheter Electrosurgery (LAMPOON and BASILICA techniques), para-valvular leak closure, percutaneous treatment of mitral valve regurgitation including Mitraclip and Transcatheter Mitral Valve Replacement (TMVR), LAA occluder, percutaneous pulmonary and tricuspid valve interventions, and cerebral protection devices for TAVR.

A vascular surgeon at Arizona Heart Institute, Phoenix, AZ, USA. Features in 6 videos on Wondr Medical. Venkatesh Ramaiah generally speaks on Abdominal Aortic Aneurysm (AAA), Live Cases, Chronic Total Occlusion (CTO), Drug Coated Balloon (DCB), and Orbital Atherectomy .

Werner Mohl is a consultant cardiothoracic surgeon at Medical University Vienna, Vienna, Austria.

William Bachinsky works at PinnacleHealth Cardiovascular Institute, Enola, PA, USA.

Works at Lankenau Heart Institute, Main Line Health, Wynnewood, PA. Features in 8 videos on Wondr Medical. William Gray generally speaks on Stroke, Peripheral Vascular Disease (PVD), Stroke: LAA and LAA closure, Left Atrial Appendage (Closure), and Venous (PVD).

William Weintraub works at Christiana Care Health System, Newark, DE, USA.

Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.

Dr. Ziyad Ghazzal earned his MD at AUB Faculty of Medicine and completed his residency in internal medicine at AUBMC in 1984. Dr. Ghazzal has upheld an academic rigor in all his professional life, becoming an internationally renowned interventional cardiologist who has excelled as a highly accomplished clinician, researcher, and teacher/ mentor. He was promoted to Professor of Medicine at Emory University, Atlanta, GA, where he has been a full-time faculty member since 1990, after completing his fellowship training at the same institution from 1985 to 1990. Dr. Ghazzal has published extensively in the cardiology literature, including high-quality original papers and many other reviews, editorials, book chapters, and video seminars. He is regularly sought after by international organizations for clinical lectures, tutorials, and other CME activities in the area of interventional cardiology. As a director of the Interventional Fellowship Program at Emory, Dr. Ghazzal has played an instrumental role in the success of the training program there, one of the premier programs in the United States. He has been a member of a large number of prospective multicenter clinical trials, including being the local principal investigator at Emory. He was an associate editor of the popular 'Cardiosource', the official teaching website of the American College of Cardiology. He was also the co-chair of the international distant learning program of the College. He is an editorial consultant for JACC Cardiovascular Interventions and the American Journal of Cardiology. Dr. Ghazzal is an Alpha Omega Alpha member and has received many honors, including the Medical Leadership Award from the National Association of North America, and the Excellence in Teaching Award from Emory University. In 2008 Dr. Ghazzal joined the American University of Beirut where he functioned as the Deputy to the Executive Vice President/Dean of the Faculty of Medicine and Medical Center in addition to his duties as an interventional cardiologist. He was appointed interim Medical Center Director and Chief Medical Officer (2017-2020). He is the Founding Director of the Heart & Vascular Institute and currently serves as the Director of the Moufid Farra Heart, Vascular & Kidney outpatient center.